Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030

Published Date: Mar 2022
Pages: 117
Format: PDF
Report ID: PM2355
Base Year: 2021
Historical Data: 2018 - 2020

Report Scope

Pharmacovigilance Market, Service Provider Outlook (Revenue, USD Billion, 2018 - 2030)

In-house
Contract Outsourcing

Pharmacovigilance Market, Product Life Cycle Outlook (Revenue, USD Billion, 2018 - 2030)

Pre-clinical
Phase I
Phase II
Phase III
Phase IV

Pharmacovigilance Market, Type Outlook (Revenue, USD Billion, 2018 - 2030)

Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

Pharmacovigilance Market, Process Flow Outlook (Revenue, USD Billion, 2018 - 2030)

Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
Risk Management System
- Risk Evaluation System
- Risk Mitigation System

Pharmacovigilance Market, Therapeutic Area Outlook (Revenue, USD Billion, 2018 - 2030)

Oncology
Neurology
Cardiology
Respiratory Systems
Others

Pharmacovigilance Market, End-Use Outlook (Revenue, USD Billion, 2018 - 2030)

Pharmaceuticals
Biotechnology Companies
Medical Device Manufacturers
Others

Pharmacovigilance Market, Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America
- Service Provider Outlook
  - In-house
  - Contract Outsourcing
- Product Life Cycle Outlook
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Type Outlook
  - Spontaneous Reporting
  - Intensified ADR Reporting
  - Targeted Spontaneous Reporting
  - Cohort Event Monitoring
  - EHR Mining
- Process Flow Outlook
  - Case Data Management
    - Case Logging
    - Case Data Analysis
    - Medical Reviewing & Reporting
  - Signal Detection
    - Adverse Event Logging
    - Adverse Event Analysis
    - Adverse Event Review & Reporting
  - Risk Management System
    - Risk Evaluation System
    - Risk Mitigation System
- Therapeutic Area Outlook
  - Oncology
  - Neurology
  - Cardiology
  - Respiratory Systems
  - Others
- End-Use Outlook
  - Pharmaceuticals
  - Biotechnology Companies
  - Medical Device Manufacturers
  - Others
Europe
- Service Provider Outlook
  - In-house
  - Contract Outsourcing
- Product Life Cycle Outlook
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Type Outlook
  - Spontaneous Reporting
  - Intensified ADR Reporting
  - Targeted Spontaneous Reporting
  - Cohort Event Monitoring
  - EHR Mining
- Process Flow Outlook
  - Case Data Management
    - Case Logging
    - Case Data Analysis
    - Medical Reviewing & Reporting
  - Signal Detection
    - Adverse Event Logging
    - Adverse Event Analysis
    - Adverse Event Review & Reporting
  - Risk Management System
    - Risk Evaluation System
    - Risk Mitigation System
- Therapeutic Area Outlook
  - Oncology
  - Neurology
  - Cardiology
  - Respiratory Systems
  - Others
- End-Use Outlook
  - Pharmaceuticals
  - Biotechnology Companies
  - Medical Device Manufacturers
  - Others
Asia Pacific
- Service Provider Outlook
  - In-house
  - Contract Outsourcing
- Product Life Cycle Outlook
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Type Outlook
  - Spontaneous Reporting
  - Intensified ADR Reporting
  - Targeted Spontaneous Reporting
  - Cohort Event Monitoring
  - EHR Mining
- Process Flow Outlook
  - Case Data Management
    - Case Logging
    - Case Data Analysis
    - Medical Reviewing & Reporting
  - Signal Detection
    - Adverse Event Logging
    - Adverse Event Analysis
    - Adverse Event Review & Reporting
  - Risk Management System
    - Risk Evaluation System
    - Risk Mitigation System
- Therapeutic Area Outlook
  - Oncology
  - Neurology
  - Cardiology
  - Respiratory Systems
  - Others
- End-Use Outlook
  - Pharmaceuticals
  - Biotechnology Companies
  - Medical Device Manufacturers
  - Others
Latin America
- Service Provider Outlook
  - In-house
  - Contract Outsourcing
- Product Life Cycle Outlook
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Type Outlook
  - Spontaneous Reporting
  - Intensified ADR Reporting
  - Targeted Spontaneous Reporting
  - Cohort Event Monitoring
  - EHR Mining
- Process Flow Outlook
  - Case Data Management
    - Case Logging
    - Case Data Analysis
    - Medical Reviewing & Reporting
  - Signal Detection
    - Adverse Event Logging
    - Adverse Event Analysis
    - Adverse Event Review & Reporting
  - Risk Management System
    - Risk Evaluation System
    - Risk Mitigation System
- Therapeutic Area Outlook
  - Oncology
  - Neurology
  - Cardiology
  - Respiratory Systems
  - Others
- End-Use Outlook
  - Pharmaceuticals
  - Biotechnology Companies
  - Medical Device Manufacturers
  - Others
Middle East & Africa
- Service Provider Outlook
  - In-house
  - Contract Outsourcing
- Product Life Cycle Outlook
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Type Outlook
  - Spontaneous Reporting
  - Intensified ADR Reporting
  - Targeted Spontaneous Reporting
  - Cohort Event Monitoring
  - EHR Mining
- Process Flow Outlook
  - Case Data Management
    - Case Logging
    - Case Data Analysis
    - Medical Reviewing & Reporting
  - Signal Detection
    - Adverse Event Logging
    - Adverse Event Analysis
    - Adverse Event Review & Reporting
  - Risk Management System
    - Risk Evaluation System
    - Risk Mitigation System
- Therapeutic Area Outlook
  - Oncology
  - Neurology
  - Cardiology
  - Respiratory Systems
  - Others
- End-Use Outlook
  - Pharmaceuticals
  - Biotechnology Companies
  - Medical Device Manufacturers
  - Others

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Implant Procedure benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2018 - 2030
Market size and revenue estimates for service provider up to 2030
Market revenue estimates for product life cycle up to 2030
Market revenue estimates for type up to 2030
Market revenue estimates for process flow up to 2030
Market revenue estimates for therapeutic area up to 2030
Market revenue estimates for end-use up to 2030
Regional market size and forecast up to 2030
Company financials

License and Pricing

Single User - $ 4,250 Multi Users (Up to 20 User) - $ 5,250 Enterprise License - $ 6,250 Buy Now

Purchase Report Sections

Regional analysis
Segmentation analysis
Industry outlook
Competitive landscape

Request for Discount Pricing

Connect With Experts

+1-646-568-9980 sales@polarismarketresearch.com Speak to Analyst Request for Customization